Atlas Trials

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

Clinical trial NCT02856802 · COMPLETED

Trial details

NCT number
NCT02856802
Sponsor
Upsher-Smith Laboratories
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Migraine Headaches
Start date
2016-07-11
Primary completion
2017-02-10
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.